Ignite Creation Date:
2025-12-26 @ 10:58 AM
Ignite Modification Date:
2026-01-25 @ 3:33 AM
Study NCT ID:
NCT00232206
Status:
TERMINATED
Last Update Posted:
2011-05-18
First Post:
2005-09-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial of Neoadjuvant Docetaxel and Cisplatin for Resectable Non-Small Cell Lung Cancer
Sponsor:
Providence Health & Services
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Non-small-Cell Lung Carcinoma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | NSCLC | View |
| None | Lung | View |
| None | Cancer | View |
| None | Metastatic | View |
| None | Neoadjuvant | View |
| None | Stage IB Non-Small Cell Lung Cancer (NSCLC) | View |
| None | IIA Non-Small Cell Lung Cancer (NSCLC) | View |
| None | IIB Non-Small Cell Lung Cancer (NSCLC) | View |
| None | Some IIIA Non-Small Cell Lung Cancer (NSCLC) | View |